Ovarian cancer: recent progress in surgery and chemotherapy
Capen, C.V.; Magrina, J.F.; Masterson, B.J.
Journal of the Kansas Medical Society 83(3): 128-129; 151
1982
ISSN/ISBN: 0022-8699 PMID: 7077115 Document Number: 190940
Document emailed within 1 workday
Related Documents
Venesmaa, P. 1994: Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstetrics and Gynecology 84(1): 8-11Szepesi, T.; Szalay, S.; Breitenecker, G.; Schratter-Sehn, A.; Rogan, A.M.; Riss, T.; Wittich, G.; Heckenthaler, W.; Fasching, W.; Scheiber, V. 1983: Treatment of advanced ovarian cancer as an interdisciplinary task: surgery, histopathology, radiotherapy, and chemotherapy Wiener Klinische Wochenschrift 95(2): 37-49
Markowska, J.; Madry, R.ła.; Kierzkowski, J.; Malicki, J.; Roszak, A.; Lubin, J.; Bratos, K. 2003: Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure Ginekologia Polska 74(9): 799-804
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Menczer, J. 1990: Ovarian cancer--progress and stagnation Harefuah 118(3): 161-164
Iwai, S. 1986: Progress of chemotherapy in various fields--surgery (postoperative infections) Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 884-888
Young, R.C. 1984: Ovarian cancer treatment: progress or paralysis? Seminars in Oncology 11(3): 327-329
Fujimoto, T. 1992: Current progress in cancer chemotherapy for childhood cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 579-587
Ozols, R.F.; Young, R.C. 1991: Chemotherapy of ovarian cancer Seminars in Oncology 18(3): 222-232
Ochiai, K. 1994: Tumors. a. Chemotherapy of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 46(8): 821-831
Anselmo-Murphy, A.M. 2009: Challenges of IP chemotherapy for ovarian cancer Oncology 23(11 Suppl Nurse Ed): 21-22
Paulus, A.; Gennigens, C.; Fillet, G.; Loly, C.; Sautois, B. 2007: Chemotherapy of ovarian cancer: state of the art Revue Medicale de Liege 62(9): 539-547
Camci, C.; Balat, O. 2002: Neoadjuvant chemotherapy in ovarian cancer European Journal of Gynaecological Oncology 23(5): 437-441
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Onda, T. 2012: Neoadjuvant chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 882-886
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Zamurovic, M.; Jurisic, A.; Andjelic, S. 2010: Systemic chemotherapy--before or after radical surgery in treatment of patients with advanced ovarian carcinoma? European Journal of Gynaecological Oncology 31(5): 564-566